Top Page
Aurora Labs
(Sydney:A3D)
Aurora Labs (A3D) vs. iShares MSCI Australia ETF (EWA)
Aurora Labs Business Overview & Revenue Model
Aurora Labs Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 743.83K | 743.83K | 174.30K | 134.56K | 32.20K | 171.62K |
| Gross Profit | -1.50M | 326.65K | 57.13K | 58.81K | 13.89K | -145.00K |
| EBITDA | -4.54M | -4.54M | -3.23M | -3.37M | -3.70M | -4.81M |
| Net Income | -3.75M | -3.75M | -2.81M | -2.96M | -3.15M | -4.42M |
Balance Sheet | ||||||
| Total Assets | 2.91M | 2.91M | 3.08M | 2.18M | 3.35M | 2.91M |
| Cash, Cash Equivalents and Short-Term Investments | 1.16M | 1.16M | 1.65M | 986.80K | 1.95M | 1.37M |
| Total Debt | 956.01K | 956.01K | 842.94K | 65.39K | 160.53K | 252.00K |
| Total Liabilities | 1.84M | 1.84M | 1.30M | 719.35K | 716.58K | 711.20K |
| Stockholders Equity | 1.07M | 1.07M | 1.78M | 1.46M | 2.63M | 2.20M |
Cash Flow | ||||||
| Free Cash Flow | -2.80M | -2.80M | -2.41M | -2.60M | -2.68M | -1.68M |
| Operating Cash Flow | -2.62M | -2.62M | -2.40M | -2.57M | -2.63M | -1.68M |
| Investing Cash Flow | -180.58K | -180.58K | -7.69K | -23.07K | -48.42K | 6.86K |
| Financing Cash Flow | 2.35M | 2.31M | 3.07M | 1.63M | 3.25M | 1.72M |
Aurora Labs Technical Analysis
Aurora Labs Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | €33.60M | 8.91 | 17.38% | 0.69% | -8.28% | 89.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | AU$15.19M | 20.63 | 6.19% | ― | -6.52% | -20.79% | |
50 Neutral | AU$16.62M | 17.96 | 4.57% | 4.29% | -15.54% | -26.61% | |
41 Neutral | AU$107.74M | -12.50 | -35.18% | ― | 0.88% | 4.88% | |
39 Underperform | €20.21M | ― | -264.05% | ― | 327.10% | 1.01% | |
38 Underperform | AU$228.63M | -6.25 | -59.01% | ― | 722.02% | -0.77% |
Aurora Labs Corporate Events
Aurora Labs has made significant strides in its propulsion development programs, transitioning its micro gas turbines from development to pre-production. The company has commenced durability testing for its AU4 engines and launched a pilot production batch of micro turbine engines. Significant contracts and agreements, including a $450,000 contract with the Australian Defence Force and a partnership with Sovereign Propulsion Systems, highlight Aurora’s growing influence in the defense sector. Additionally, a Defence Industry Development Grant will aid in production upgrades, positioning Aurora to meet military standards and expand its market reach.
Aurora Labs Ltd has announced the issuance of 60,435,585 fully paid ordinary shares, raising approximately $3.1 million. This move, involving both a placement to sophisticated investors and the conversion of unlisted options, is part of the company’s strategic efforts to strengthen its financial position and support its operational goals.
Aurora Labs Limited has announced the application for the quotation of 833,334 ordinary fully paid securities on the Australian Securities Exchange (ASX), set to be issued on October 21, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its growth initiatives in the competitive 3D printing industry.
Aurora Labs Limited has announced the application for the quotation of 59,602,251 ordinary fully paid securities on the Australian Securities Exchange (ASX), with the issue date set for October 21, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and provide additional capital for its operations, potentially impacting its industry positioning and offering new opportunities for stakeholders.
Aurora Labs Limited has announced its upcoming annual general meeting, scheduled to take place on November 17, 2025, in Perth, Western Australia. Shareholders are encouraged to participate by submitting questions in advance and voting by proxy if unable to attend. The meeting will cover the company’s annual report, including financial and directors’ reports, and will consider a resolution on the remuneration report, which is advisory and non-binding.
Aurora Labs has entered into a Joint Integration, Testing, Development, and Distribution Agreement with Sovereign Propulsion Systems (SPS) to test and commercialize its novel turbine engines for the defense sector. Under this agreement, SPS will manage a comprehensive testing program at its South Australian facility, integrating Aurora’s engines into various platforms and conducting performance analyses. SPS will also act as a distributor for Aurora’s propulsion systems, with funding provided in kind through distribution rights. This collaboration is expected to enhance Aurora Labs’ market positioning in the defense industry by leveraging SPS’s expertise in UAV and robotic systems.
Aurora Labs Limited announced a proposed issue of 46,166,980 ordinary fully paid securities, with the issuance date set for November 21, 2025. This move is part of a placement or other type of issue, which could impact the company’s capital structure and potentially enhance its market positioning by providing additional funds for growth and development initiatives.
Aurora Labs Limited has announced a proposed issue of 59,602,251 ordinary fully paid securities, with the issuance date set for October 21, 2025. This move is part of a placement or other type of issue, which could potentially enhance the company’s capital structure and support its growth initiatives in the competitive 3D printing market.
Aurora Labs has successfully raised $5.5 million through a Two Tranche Placement, with significant backing from both existing and new investors, including a strategic investment from Sovereign Propulsion Systems (SPS). This capital will be used to advance Aurora’s drone propulsion business, expand manufacturing capacity, and provide working capital. The collaboration with SPS, which includes aerial testing of next-generation propulsion systems, marks a critical milestone for Aurora as it seeks to commercialize its technology and strengthen its position within Australia’s sovereign defence supply chain. This partnership also grants SPS exclusive distribution rights to Aurora’s propulsion system across AUKUS partner countries for a three-year term.
Aurora Labs Limited has requested a trading halt on its securities as it prepares to make an announcement regarding a proposed capital raising. This move is aimed at strengthening its financial position and potentially expanding its operations. The trading halt will remain in effect until the announcement is made or until normal trading resumes on October 14, 2025, whichever comes first. This development could have significant implications for Aurora Labs’ market positioning and stakeholder interests as it seeks to enhance its capital base.
Aurora Labs Ltd has announced the appointment of David Trimboli as a director, effective from October 7, 2025. This appointment includes Trimboli’s significant interests in the company through Seefeld Investments Pty Ltd, holding over 4.3 million fully paid ordinary shares and options. This strategic move is expected to strengthen Aurora Labs’ leadership and potentially enhance its market position in the 3D printing industry.
Aurora Labs has announced a board restructure to support its growth in the Defence sector, appointing Mr. David Trimboli as the new Chairman and elevating Andrew Garth to Executive Director- Strategy & Strategic Partnerships. Mr. Trimboli, with extensive experience in global commodities trading and investment, is expected to enhance Aurora’s international business network. Meanwhile, Mr. Garth, with a strong background in Defence and advanced manufacturing, will focus on strategic relationships and guidance as the company advances its UAS propulsion systems for Defence. These changes are aimed at strengthening Aurora’s market position and driving growth in the Defence industry.
Aurora Labs has secured a $450,000 Phase 2 contract with the Australian Department of Defence for the prototype manufacture and testing of a high-thrust, fuel-efficient propulsion system. This development builds on the successful completion of Phase 1, leveraging Aurora’s proprietary 3D printing technology. The project enhances Aurora’s propulsion portfolio, positioning the company as a leader in small engine propulsion for Defence and opening opportunities for partnerships with UAS developers. The contract allows Aurora to retain global commercialization rights, ensuring potential growth in both domestic and export markets.
Aurora Labs Limited announced the cessation of 7,000,000 securities due to the expiration of options without exercise or conversion as of September 30, 2025. This development may impact the company’s capital structure and could influence its strategic financial planning, potentially affecting investor perceptions and market positioning.
Aurora Labs has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations, highlighting their commitment to transparency and accountability. This announcement reinforces Aurora Labs’ dedication to maintaining robust governance practices, which is crucial for stakeholder trust and long-term strategic positioning in the competitive 3D printing market.
Aurora Labs Limited reported a significant increase in revenue for the year ended June 30, 2025, with a 327% rise to $743,831 compared to the previous year. Despite the revenue growth, the company experienced a 34% increase in loss after tax, amounting to $3,750,875. The financial results indicate a challenging period for the company, with increased losses potentially impacting its market positioning and stakeholder confidence.
Aurora Labs Limited has announced the receipt of its 2025 Research and Development tax refund amounting to $924,374. The company has utilized part of this refund to fully repay a $500,000 short-term loan facility, which was secured against the R&D tax credit. This repayment, along with accrued interest, has closed out the loan facility, leaving Aurora Labs with approximately $406,189 added to its existing cash reserves. This financial maneuver strengthens the company’s cash position, potentially enhancing its operational capabilities and market positioning.